The Bruton's tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody-mediated T-cell cytotoxicity.
Colin D GodwinOlivia M BatesEliotte E GarlingMary E BeddoeGeorge S LaszloRoland Bruno WalterPublished in: British journal of haematology (2020)
Keyphrases